ClinicalTrials.gov
public full text
Public Domain
ALTO-100 in Bipolar Disorder With Depression (BD-D)
The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depressive episode, when used adjunctively to a mood stabilizer and/or atypical antipsychotic, related to patient characteristics. Additionally, safety, tolerability, and efficacy will be assessed in a subsequent open label treatment period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder#895786
- PD, PK, and Safety of ALTO-203 in Patients With MDD#858254
- Accelerated Intermittent Theta Burst Stimulation in Unipolar Versus Bipolar Depression#856875
- Cost- Effectiveness and Quality of Life Assessment in Mood Disorder#834543
- Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.#881254
Record · ID 993256
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive